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Objective: This study was undertaken to evaluate factors contributing to a decrease
in early mortality and morbidity after the Fontan procedure between January 1,
1992, and December 31, 1999.
Methods: Outcomes evaluated were early survival, duration of pleural effusions,
and duration of hospitalization. Potential predictors evaluated included anatomic
diagnosis, presence of a common atrioventricular valve, preoperative pulmonary
artery pressure, type of Fontan operation, type of intentional right-to-left shunt or
baffle fenestration, and use of modified ultrafiltration.
Results: The modified Fontan procedure was performed in 332 patients at a median
age of 22 months (range, 11-380 months) and a median weight of 11 kg (range, 5.8-
120 kg). Prior stage I reconstructive surgery for classic or variant hypoplastic left
heart syndrome had been performed in 205 (53%) of 332 patients, and 318 (96%)
had undergone an interim superior cavopulmonary connection. A lateral-tunnel
Fontan operation was performed in 281 patients, and an extracardiac conduit Fontan
operation was performed in 51 patients. An intentional right-to-left shunt was created
in 298 (90%) patients. Between 1992 and 1999, the outcome after the modified
Fontan operation improved significantly. Overall mortality was 6.6% (22/332), with
only 2 deaths since 1994. Morbidity was also reduced, with a decreased duration of
pleural effusions and decreased hospital stay. In a multivariable analysis of the entire
cohort, only the presence of a common atrioventricular valve (odds ratio, 7.64; 95%
confidence limits, 2.07-28.14; P = .0002) and increased preoperative pulmonary
artery pressure (odds ratio, 1.46/1 mm Hg increase; 95% confidence limits, 1.2-1.78;
P < .001) increased the risk of early death, whereas use of a single-punch fenestra-
tion in a lateral-tunnel Fontan (odds ratio, 0.06; 95% confidence limits, 0.01-0.65; P
= .02) and use of modified ultrafiltration (odds ratio, 0.14; 95% confidence limits,
0.03-0.72; P = .019) decreased the risk of death. The risk of prolonged pleural effu-
sions (>3 days) was increased in patients with hypoplastic left heart syndrome (odds
ratio, 1.73; 95% confidence limits, 1.07-2.81; P = .03) and was decreased by use of
a single-punch fenestration in a lateral-tunnel Fontan operation (odds ratio, 0.17;
95% confidence limits, 0.07-0.4; P < .001), as well as by the use of modified ultra-
filtration (odds ratio, 0.25; 95% confidence limits, 0.15-0.40; P < .01).
Conclusions: In a contemporary series of Fontan operations performed largely in
patients with hypoplastic left heart syndrome or variants, systemic ventricle mor-
phology had no effect on mortality. Some patient characteristics, however, continue
to influence outcome. The decrease in mortality and morbidity in the current era is
attributed to changes in management strategies, specifically the use of modified
ultrafiltration and baffle fenestration.
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Management strategies for neonates and infantswith a functional single ventricle have evolvedsignificantly in recent years, with most under-going a series of staged palliative procedures
culminating in a modified Fontan operation. Mortality and
morbidity after the Fontan operation have been dramatically
reduced in recent years. A variety of modifications of the
Fontan operation have been introduced, including interim
superior cavopulmonary connection, baffle fenestration, the
lateral-tunnel Fontan procedure, and the extracardiac con-
duit Fontan procedure. Improved outcome after stage I
reconstruction for patients with hypoplastic left heart syn-
drome (HLHS) has led to an increasing number of these
patients undergoing the Fontan operation. Previous reports
have suggested that HLHS was a risk factor for mortality
after the Fontan operation. The current study was under-
taken to review our institutional experience with the modi-
fied Fontan operation in a cohort of patients composed
largely of subjects with HLHS or variants to identify patient
and management characteristics that might influence early
mortality and morbidity.
Methods and Patients
Patient Population
The study was approved by the Institutional Review Board of The
Children’s Hospital of Philadelphia. Review of the Cardiology and
Cardiac Surgery Databases at The Children’s Hospital of
Philadelphia identified 332 patients who underwent a modified
Fontan operation between January 1, 1992, and December 31, 1999.
Perioperative Data Acquisition
Patient-related variables. Demographic and anatomic vari-
ables were recorded from the medical record (Table 1). Patients
were assigned to one of 6 diagnostic groups on the basis of cardiac
anatomy (Table 2). The atrioventricular (AV) valve anatomy was
classified as a common AV valve or “other” on the basis of the pre-
operative echocardiogram. AV valve regurgitation was classified
as none, mild, moderate, or severe on the basis of the preoperative
echocardiogram. The mean pulmonary arterial pressure and ven-
tricular end-diastolic pressure were recorded from the preoperative
cardiac catheterization.
Procedure-related variables. During the study period, 2 tech-
niques for the creation of the systemic venous pathway were used
exclusively: either a lateral tunnel with an intra-atrial baffle or an
extracardiac conduit connection. No patient underwent an atri-
opulmonary connection. Use and type of intentional right-to-left
shunt were recorded, as were details of intraoperative management
(Table 1).
Postoperative variables. The duration of hospital stay (in days)
was recorded. The duration of pleural drainage (in days) was
defined as the period from the date of the operation until
the last thoracentesis or final removal of pleural catheters.
Prolonged pleural effusions were considered as pleural effusions
requiring drainage for greater than 3 days. Very prolonged effu-
sions were defined as those necessitating drainage for greater than
14 days. Prolonged hospital stay was defined as 14 days or longer.
TABLE 1. Preoperative variables
Demographics Age at operation
Year of operation
Weight
Diagnosis Single left ventricle with normally
related great arteries
Single left ventricle with transposed
great arteries
Single right ventricle
HLHS
Heterotaxy syndrome
Other
AV valve anatomy Common AV valve
Other
AV valve regurgitation None
Mild
Moderate
Severe
Initial procedure None
Balloon atrial septostomy
Pulmonary artery band
Pulmonary artery band with
coarctation repair
Aortopulmonary shunt
Stage I with interrupted aortic arch
repair
Stage I
Superior cavopulmonary None
connection Bidirectional Glenn shunt
Hemi-Fontan
Bilateral cavopulmonary connection
Preoperative hemodynamics Mean pulmonary arterial pressure
Ventricular end-diastolic pressure
Procedure-related variables
Type of Fontan Lateral tunnel
Extracardiac conduit
Creation of intentional Yes/No
right-to-left shunt
Type of intentional None
right-to-left shunt Adjustable atrial septal defect
Multiple small holes
Hepatic vein exclusion
Side-to-side anastomosis with
extracardiac conduit
Single-punch fenestration in
lateral-tunnel baffle
CPB time
Aortic crossclamp time
Deep circulatory arrest time
MUF Yes/No
Postoperative outcomes
Hospital mortality
(operative or <30 d)
Duration of pleural drainage
Duration of hospital stay
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Statistical Analysis
Data are presented as medians and ranges where appropriate.
Specific outcomes evaluated were hospital mortality (before hos-
pital discharge or less than 30 days postoperatively), duration of
postoperative pleural effusions, and duration of postoperative hos-
pital stay. Patient and management characteristics that were eval-
uated as possible effectors of outcome are listed in Table 1. The
effect of patient and surgical characteristics was evaluated by
means of univariate and multivariable analysis. For the univariate
analysis, the χ2 test, the Fisher exact test, and logistic regression
were used as appropriate. A P value of less than or equal to .1 was
the criterion for inclusion in the multivariable model.
Multivariable analysis was performed by means of a logistic
regression model. Results are expressed as odds ratios (ORs) with
95% confidence limits (CLs). Patient characteristics were adjusted
for year of operation in the multivariable analysis to control for
possible changes in the patient population over time. Risk factors
for prolonged effusion and hospital stay were evaluated in the hos-
pital survivors.
The effect of year of operation and operating surgeon could not
be separated from each other (Figure 1) or from certain surgical
characteristics (eg, modified ultrafiltration [MUF]). In addition, it
is expected that all surgeons’ results improve over time, and there-
fore comparing the results of one surgeon in 1992 with those of
another in 1999 would potentially introduce bias. For these rea-
sons, the effect of year of operation and operating surgeon are pre-
sented descriptively and not incorporated into the multivariable
analysis. There were no deaths among the 96 patients undergoing
a lateral-tunnel Fontan operation in whom a single-punch fenes-
tration was created; as a result, these patients would be eliminated
from a multivariable logistic regression model where death is the
outcome of interest. Therefore, a fictitious patient coded as having
died after a lateral-tunnel Fontan procedure with a single-punch
fenestration was added to the model. This fictitious patient is not
included in the descriptive data. The use of a single-punch fenes-
tration in a lateral tunnel–type Fontan operation was highly corre-
lated with the use of MUF. Their effects were therefore analyzed
in separate models. The OR and significance of other characteris-
tics in the model were not substantially different when combined
with the single-punch fenestration versus with MUF.
Results
A total of 332 patients underwent a modified Fontan proce-
dure at The Children’s Hospital of Philadelphia between
January 1, 1992, and December 31, 1999. Anatomic diag-
noses are shown in Table 2. HLHS was present in 156
(53%) of 332 patients. A common AV valve was present in
34 patients. The majority of patients underwent at least one
palliative procedure before cavopulmonary connection,
with the stage I reconstruction performed most frequently
(n = 205, 62%; Table 3). An interim superior cavopul-
monary connection was performed in 318 (96%) patients. A
hemi-Fontan procedure was performed in 257 patients, a
bidirectional Glenn shunt in 36 patients, and bilateral
cavopulmonary connections in 25 patients. At the time of
the Fontan procedure, AV valve regurgitation was absent in
211 patients, mild in 100 patients, moderate in 17 patients,
and severe in 2 patients. Preoperative echocardiograms
were not available for 2 patients.
TABLE 2. Diagnostic categories
Diagnoses No. (%)
Single left ventricle with normally related great arteries 42 (13)
Single left ventricle with transposed great arteries 46 (14)
Heterotaxy syndrome 26 (8)
Single right ventricle (not HLHS) 27 (8)
HLHS 176 (53)
Other diagnoses 15 (4)
Figure 1. Distribution of cases by surgeon and by year.
Figure 2. Type of Fontan procedure by year.
TABLE 3. Initial procedures
Procedure No. (%)
None 28 (8)
Balloon atrial septostomy 3 (1)
Pulmonary artery banding 23 (7)
Pulmonary artery banding with coarctation repair 4 (1)
Aortopulmonary shunt 64 (19)
Stage I procedure 205 (62)
Stage I procedure with interrupted aortic arch repair 5 (2)
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The median age at the time of the operation was 22
months (range, 11-380 months), and the median weight was
11 kg (range, 5.8-120 kg). A lateral tunnel–type Fontan
connection was created in 281 patients, and extracardiac
conduits were used in 51 patients (Figure 2). An intentional
right-to-left shunt was created in 298 (90%) patients. The
type of shunt varied according to the year of the operation.
Early in the series, hepatic vein exclusion or multiple,
small-baffle fenestrations were used, whereas in the most
recent era, use of a single-punch fenestration in a lateral-
tunnel baffle or a side-to-side anastomosis between the
extracardiac conduit and atrial wall were used exclusively
(Table 4 and Figure 3). Whenever possible, associated
lesions, such as AV valve regurgitation and pulmonary
artery stenosis, were addressed at the time of the superior
cavopulmonary connection to avoid the need for additional
procedures at the time of Fontan completion. Additional
procedures were performed at the time of the Fontan proce-
dure in 16 patients, including atrial septectomy in 8, tricus-
pid valve repair in 7, and arch augmentation in 1. The
median duration of cardiopulmonary bypass (CPB) was 60
minutes (range, 32-236 minutes). A period of deep
hypothermic circulatory arrest (DHCA) was used in 319
patients, with a median duration of 24 minutes (range, 12-
93 minutes). Continuous CPB with bicaval cannulation was
used in the remaining 13 patients (all extracardiac con-
duits). The median duration of aortic crossclamping was 26
minutes (range, 12-99 minutes). For patients undergoing a
lateral-tunnel Fontan procedure with a single-punch fenes-
tration, the median duration of CPB was 56 minutes (range,
40-147 minutes). The median duration of aortic cross-
clamping was 17 minutes (range, 12-60 minutes), with a
median duration of DHCA of 17 minutes (range, 12-59
minutes). MUF was introduced in December 1995 and was
used in all subsequent patients.
Overall, there were 22 deaths among the 332 patients in
the study, for a mortality of 6.6%. The yearly mortality
ranged from 0% to 17% (Figure 4) and decreased signifi-
cantly after 1994 (P < .001). Since 1994, mortality after the
Fontan procedure has been 1% (2/174). During the study
period, Fontan failure during the early postoperative period,
requiring takedown to a cavopulmonary connection or car-
diac transplantation, occurred in 4 patients. Of these, 3
patients operated on in 1993 (n = 2) and 1994 (n = 1) died
Figure 3. Type of intentional right-to-left shunt by year. LT, Lateral
tunnel; EC, extracardiac conduit; ASD, atrial septal defect.
Figure 4. Fontan mortality by year of surgery. There was a signifi-
cant decrease in mortality between 1994 and 1995, from 17% to 3%
(P = .026). In addition, when the years 1992 through 1994 are com-
pared with the later era of 1995 through 1999, there is a statisti-
cally significant decrease in overall mortality (P < .001).
Figure 5. Duration of effusions (in days) by year of operation. There
was a dramatic decrease in the duration of effusions between
1994 and 1995. The median duration of pleural drainage for each
year is shown at the bottom of the figure.
TABLE 4. Right-to-left shunts
Type of intentional right-to-left shunt No. (%)
None 34 (10)
Adjustable atrial septal defect 6 (2)
Multiple small holes 85 (26)
Partial hepatic vein exclusion 65 (20)
Side-to-side anastomosis between extracardiac conduit 40 (12)
and atrial wall
Single-punch fenestration in lateral-tunnel baffle 96 (29)
Type of fenestration not determined 6 (2)
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after takedown of the Fontan procedure to a superior
cavopulmonary connection, and 1 patient (1997) underwent
orthotopic cardiac transplantation and survived. In the mul-
tivariable analysis characteristics that increased the risk of
death included the presence of a common AV valve (versus
all other AV valve types; OR, 7.64; 95% CL, 2.07-28.14; P
= .002) and increased mean pulmonary artery pressure at
the preoperative cardiac catheterization (OR, 1.46/1 mm Hg
increase; 95% CL, 1.2-1.78; P < .001; Table 5).
Characteristics that decreased the risk of death in the multi-
variable analysis were use of a single-punch fenestation in
the lateral-tunnel Fontan operation (OR, 0.06; 95% CL,
0.01-0.65; P = .02) and the use of MUF (OR, 0.14; 95% CL,
0.03-0.72; P = .019).
The median duration of postoperative pleural drainage
among survivors was 2 days (range, 1-258 days), and this
decreased significantly after 1994 (P < .001, Figure 5). A
diagnosis of HLHS, however, was associated with an
increased risk of prolonged effusion (OR, 1.73; 95% CL,
1.07-2.81; P = .03; Table 6). The duration of pleural drainage
was related to the type of fenestration (Tables 7 and 8). Use
of single-punch fenestration in a lateral-tunnel Fontan opera-
tion in patients with HLHS reduced the OR for prolonged
effusions to 0.47. Use of MUF in patients with HLHS
reduced the OR for prolonged pleural drainage to 0.91.
Creation of an extracardiac conduit Fontan with a side-by-
side anastomosis and a lateral-tunnel Fontan with a single-
punch fenestration were both found to significantly reduce
the incidence of very prolonged pleural effusions (>14 days,
Table 7). Other types of intentional right-to-left shunts
(hepatic vein exclusion and multiple small-baffle fenestra-
tions) did not reduce the incidence of prolonged effusions.
TABLE 5. Variables with no demonstrated effect on mortality
Age
Weight
Anatomic diagnosis 
AV valve insufficiency
Ventricular end-diastolic pressure
Heterotaxy syndrome
Initial procedure
Type of staging operation
Type of Fontan operation
Crossclamp time
CPB time
DHCA time
TABLE 6. Variables with no demonstrated effect on duration
of pleural drainage
Age
Weight
Presence of common AV valve 
AV valve insufficiency
Preoperative pulmonary arterial pressure
End-diastolic ventricular pressure
Initial procedure
Type of staging operation
Type of Fontan operation
Crossclamp time
CPB time
DHCA time
TABLE 7. Duration of pleural effusions by type of Fontan baffle fenestration
Type of baffle fenestration No. of patients Days of pleural drainage (median) Days of pleural drainage (range)
None 33 7 1-258
Adjustable ASD 6 8 1-53
Hepatic vein exclusion 58 7 1-253
Multiple small holes 77 2 1-213
Single-punch hole in lateral tunnel 93 1 1-29
Single hole in extracardiac conduit 38 1 1-24
TABLE 8. Effect of type of international right-to-left shunt on duration of pleural drainage
Type of fenestration OR (95% CL) for drainage >3 d P value OR (95% CL) for drainage >14 d P value
Adjustable ASD 1.58 (0.25-9.82) .49 0.71 (0.11-4.45) .72
Multiple small holes 1.38 (0.61-3.09) .44 1.00 (0.45-2.24) 1.00
Hepatic vein exclusion 0.72 (0.31-1.66) .44 0.78 (0.33-1.83) .57
Extracardiac conduit with side-by-side hole 0.053 (0.21-1.33) .18 0.25 (0.08-0.76) .01
Lateral tunnel with single-hole punch 0.18 (0.08-0.42) <.001 0.13 (0.05-0.34) <.001
ASD, Atrial septal defect.
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The median length of hospital stay among survivors was
9 days (range, 3-142 days). As with mortality and prolonged
effusions, the incidence of prolonged hospitalization
decreased significantly after 1994 (P < .001, Figure 6).
Patients with HLHS had a significantly increased risk of
prolonged hospitalization (OR, 2.24; 95% CL, 1.23-2.07; P
= .008). The risk of prolonged hospitalization was
decreased by use of a single-punch fenestration in a lateral-
tunnel Fontan operation (OR, 0.09; 95% CL, 0.03-0.4; P <
.001), as well as by use of MUF (OR, 0.07; 95% CL, 0.03-
0.16; P < .002).
Discussion
Management of neonates with a functional single ventricle
has evolved considerably in the 3 decades since the intro-
duction of the Fontan operation. Most of these infants
undergo a series of staged reconstructive operations begin-
ning in the neonatal period and culminating in an eventual
Fontan procedure. The goals of neonatal management
include creation of unobstructed systemic outflow and pul-
monary venous pathways, limitation of pulmonary blood
flow to prevent development of pulmonary vascular disease,
and avoidance of pulmonary artery distortion. A variety of
technical modifications have been introduced since the first
report of the Fontan operation,1-3 including staging with an
interim superior cavopulmonary connection,4,5 use of an
intra-atrial baffle to create a lateral-tunnel Fontan,6 creation
of an intentional right-to-left shunt (baffle fenestration),7-9
and introduction of the extracardiac conduit Fontan.10
Because of improved management in the neonatal period
and early infancy, an increasing number of patients previ-
ously thought to be at high risk, specifically those with
HLHS, are being referred for the Fontan operation.11
Despite the change in patient population, there has been a
dramatic reduction in mortality and morbidity after the
Fontan operation. Multiple factors, some difficult to mea-
sure, probably have contributed to the decline in mortality
and morbidity, including modifications of the procedure
and improved pre-Fontan management of infants with sin-
gle ventricle, as well as improvements in CPB, anesthesia
management, and intensive care unit care.
Our study reports a single-institution experience with a
large number of patients undergoing the modified Fontan
procedure in the current era. Despite a patient population
composed largely of patients with HLHS or variants, mor-
tality has decreased dramatically in recent years, as has
morbidity, especially prolonged pleural effusions. In con-
trast to previous reports, HLHS was not a risk factor for
mortality. However, a diagnosis of HLHS does remain a risk
factor for morbidity, specifically for prolonged pleural effu-
sions and prolonged hospitalization. Interestingly, there was
no difference in mortality or morbidity between patients
undergoing a lateral-tunnel Fontan or an extracardiac con-
duit Fontan. However, creation of a single-punch fenestra-
tion in a lateral-tunnel Fontan operation was associated both
with the lowest mortality and the lowest morbidity, sug-
gesting that a single-punch fenestration provides a more
reliable and consistent method of baffle fenestration than
other techniques. Modifications of CPB, specifically the
introduction of MUF, were also associated with a decrease
in mortality and morbidity in this study.
Gentles and colleagues,12 from Boston Children’s
Hospital, reviewed a large (500 patients) single-center
experience of outcomes after the Fontan operation between
1973 and 1991. This early time period encompassed many
of the technical modifications and changes in management
strategies since the introduction of the Fontan operation. In
their study a higher preoperative mean pulmonary arterial
pressure, younger age at operation, presence of heterotaxy
syndrome, and presence of a tricuspid valve as the systemic
AV valve were identified as risk factors for early failure.
Use of an atriopulmonary connection–type Fontan proce-
dure and absence of baffle fenestration were also associated
with an increased risk of early failure. HLHS was present in
fewer than 10% of the patients but was noted to be a risk
factor for early death. In addition, age at the time of the
Fontan operation of less than 4 years remained a risk factor
for failure. It should be noted that the last patient in their
series was operated on in 1991, and thus their report repre-
sents the evolution of the Fontan procedure rather than
results in the current era.
Hsu and associates13 reported outcomes after a single-
stage, nonfenestrated Fontan procedure in 61 consecutive
patients between 1990 and 1996. The mean age at the time
of the operation was 3.3 years, and early mortality was
3.9%. The median duration of pleural drainage was 5.5
Figure 6. Hospital stay (in days) by year of operation. There was a
significant decrease in the duration of hospital stay between 1994
and 1995 (P = .04). In addition, when the early era of 1992 through
1994 is compared with the later era of 1995 through 1999, there is
a significant decrease in the duration of hospital stay (P < .001).
The median duration of hospital stay for each year is shown at the
bottom of the graph.
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days. However, these 61 patients represented only two
thirds of the patients undergoing the Fontan procedure at
their institution. Use of the single-stage, nonfenestrated
Fontan procedure was restricted to patients thought to be at
low risk, and there were only 2 patients with HLHS among
the 61 patients studied. Their experience demonstrated that
a single-stage, nonfenestrated Fontan procedure can be per-
formed with reasonably low morbidity and mortality in
selected patients.
Thompson and colleagues14 reported results in 81
patients undergoing an extracardiac Fontan operation
between 1992 and 1997 after a previous bidirectional Glenn
shunt. They used a technique of selective fenestration after
separation from CPB, for a pressure in the Fontan circuit of
greater than 18 mm Hg or in the transpulmonary gradient of
greater than 10 mm Hg. There were 2 operative deaths, and
prolonged chest tube drainage (>14 days) occurred in 13
patients, 8 with and 5 without fenestration. HLHS was pres-
ent in fewer than 10% of the patients. Their experience
demonstrates that an extracardiac conduit Fontan operation
without fenestration is associated with acceptable morbidity
and mortality in selected low-risk patients.
Van Arsdell and coworkers15 evaluated risk factors for
mortality and morbidity in 100 patients undergoing the
Fontan procedure between 1992 and 1995. HLHS was pres-
ent in fewer than 10% of the patients. Mortality in the first
half of the series was 16%, and it was 0% in the second 50
patients. Duration of pleural effusions and hospital stay
were also shorter in the more recent era. Patient character-
istics and risk factors were comparable throughout the
study; however, patients in the recent era of lower mortality
were more likely to have routine staging, an extracardiac
Fontan completion, and use of MUF. The authors attribute
the improvement in outcome to increasing use of the extrac-
ardiac Fontan procedure, as well as introduction of MUF
after CPB.
Mosca and associates16 recently reported the outcome of
the Fontan procedure in 100 consecutive patients with
HLHS between 1992 and 1998. Two different surgical tech-
niques were used. In the earlier era (1992-December 1995),
patients underwent a bidirectional Glenn procedure and
then a lateral-tunnel completion Fontan procedure with the
right atrium reconnected to the pulmonary artery at the time
of the Fontan operation (technique 1). In December of
1995, a new technique was introduced, whereby patients
underwent a hemi-Fontan procedure as the staging proce-
dure. The Fontan procedure (lateral tunnel) was performed
with single right atrial venous cannulation, profound
hypothermia, and a brief period of DHCA (technique 2).
Baffle fenestration with a 4-mm single-punch fenestration
was routinely used. MUF was introduced in 1996 and thus
was used only in patients undergoing technique 2. Hospital
survival for patients treated with technique 1 was 79% com-
pared with 98% for those treated with technique 2. The
findings of this study are consistent with those of the cur-
rent study in that use of a single-punch fenestration in the
lateral-tunnel conduit, as well as routine use of staging and
MUF, resulted in low mortality for the Fontan procedure in
patients with HLHS.
We previously evaluated the effects of MUF in a small
group of patients undergoing the Fontan operation.17 The
study was a retrospective review, yet it showed that use of
MUF was associated with a decrease in the duration of
pleural effusions and length of hospital stay. The patients in
that study are included in the current study. In the current
study the use of MUF was also shown to decrease mortality
and to reduce the incidence of prolonged pleural effusions
and prolonged hospitalization. Studies at other institutions
have also demonstrated beneficial effects of MUF after the
Fontan operation.15,16 The mechanisms by which MUF
results in beneficial effects have not been fully determined
but likely include removal of excess body water and inflam-
matory mediators. MUF has been shown to improve ven-
tricular function, lower pulmonary vascular resistance,
improve pulmonary compliance, and decrease postoperative
bleeding, all of which may contribute to improved outcome
after the Fontan operation.18,19
Several centers have reported improved hemodynamic
results and improved patient outcomes after the modified
Fontan operation when an intentional right-to-left shunt
(baffle fenestration or adjustable atrial septal defect) is
used.20-22 Benefits of baffle fenestration include improved
ventricular preload, increased cardiac output, improved
oxygen delivery, reduced systemic venous pressure, and
decreased severity of pleural effusion. The findings of the
current study suggest that the specific type of fenestration is
an important determinant of outcome.
The current study demonstrates that a management strat-
egy, including routine staging, effective baffle fenestration,
and use of MUF, is associated with very low mortality and
morbidity after the Fontan procedure. Because almost all
patients underwent an interim superior cavopulmonary con-
nection, the effect of staging cannot be evaluated. A variety
of techniques were used for baffle fenestration, and only
creation of a single-punch fenestration in a lateral-tunnel
baffle was associated with a decrease in both mortality and
morbidity. Neither hepatic vein exclusion nor the creation
of multiple small holes in the baffle resulted in a decrease
in the incidence of prolonged effusions. Other studies have
suggested that routine baffle fenestration is not necessary;
however, these studies included few patients with HLHS,
and the reported duration of pleural drainage has consis-
tently been longer than in the current study. The type of fen-
estration is important because techniques other than
single-punch fenestration in a lateral-tunnel baffle appear to
be less effective and less consistent.
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This study has several limitations. The study is retro-
spective. Many of the management strategies evolved over
time and are highly related to both the surgeon and the year
of the operation. Decisions, such as time of the Fontan oper-
ation, type of fenestration, and use of MUF, were made at
the surgeon’s discretion and not according to protocol. In
addition, certain practices are highly linked, such as the
side-to-side anastomosis type of fenestration and the extrac-
ardiac conduit, and thus the effects cannot be separated.
Because of the nature of the study, it is not possible to deter-
mine whether similar results could have been achieved with
alternate management strategies, such as a single-stage,
nonfenestrated Fontan procedure without MUF. However,
there are no reports of equally successful applications of
such a strategy to a large group of patients with HLHS. This
study demonstrates that a strategy of interim superior
cavopulmonary connection, effective baffle fenestration,
and use of MUF results in excellent outcome after the
Fontan operation, with very low morbidity and mortality,
even in high-risk patients, such as those with HLHS. 
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Discussion
Dr Ralph Mosca (New York, NY). I congratulate the authors on
a well-written review of a large series of patients undergoing the
Fontan procedure at the Children’s Hospital of Philadelphia. The
overall results were excellent, a tribute to the expertise of all
involved in these patients’ care. Those who care for large numbers
of these patients will attest to the fact that 15 years ago the appear-
ance of a Fontan procedure on the operating room schedule was
met with some trepidation. This often portended a difficult post-
operative time for patients and caregivers alike. The procedures
were reserved for a highly selected subgroup of patients with sin-
gle ventricle, and those with HLHS were few and far between.
Today, HLHS has become the leading diagnosis in many centers,
the procedures are routine, and the patients are fast tracked, extu-
bated early, and often discharged in a week.
I have a few questions. A common AV valve was a risk factor
for early death, yet AV valve insufficiency was not. What is it
about the presence of a common AV valve, aside from its compe-
tency, that increases the risk?
In the article, you described 19 patients with either moderate or
severe AV valve insufficiency, yet only 7 underwent attempted AV
valve repair. Despite its lack of predictive value concerning early
morbidity and mortality, do you believe that AV valve competency
is important in the long-term, and what is your policy regarding
selection of patients for valve repair?
Elevated preoperative pulmonary artery pressure was found
to be a significant risk factor for early death, with an OR of 1.46
for each millimeter increase in pressure, yet there are no refer-
ences to absolute values. At what point did this become clinically
significant?
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The punch-style fenestration decreased the risk of early death in
the lateral-tunnel group. Interestingly, there was no difference in
mortality when compared with that in the extracardiac Fontan
group. Were all these fenestrations as reliably patent? Did selection
bias favor your extracardiac group? Finally, should we, as some
groups are saying, do extracardiac Fontans if this is the result?
The median duration of pleural drainage was 2 days, the short-
est I have seen in this patient population. Many institutions keep
the tubes in place until the patients are reliably taking enteral nutri-
tion to check for increases in chylous drainage. What is your opin-
ion on these policies, and have you noticed any increase in late
postoperative effusions with early removal of the pleural tubes?
Finally, it strikes me that when viewed from the neonatal
period, survival after a Fontan procedure for single-ventricle
lesions can be likened to the challenge of a game of pool. Now that
we understand the important issues and angles involved, the mor-
phologic surface on which we are playing seems less important.
What is paramount is that each shot or stage is well made and, just
as important, sets up the next. You have certainly shown us that
this is true for HLHS.
Dr Spray. Thank you for your comments. The issue of the
common AV valve is a significant one. In the small number of
patients with a common AV valve, we could not identify the pres-
ence of AV valve regurgitation as a risk factor. The common AV
valve may therefore be a surrogate marker for some other factor.
In single-ventricle malformations, especially those with right ven-
tricular morphology, AV valve regurgitation is not uncommon
when these patients come to the Fontan operation. We have not
actually found that repair of the AV valve at that stage, unless the
regurgitation is severe, has changed the overall survival, hospital
stay, or morbidity in these patients. However, if significant AV
valve regurgitation is present at the time of the Fontan operation,
at least an attempt to limit the amount of regurgitation is war-
ranted. Unfortunately, common AV valve may be the most difficult
anomaly to repair surgically, and these patients may ultimately
come to valve replacement.
There was no absolute value of pulmonary artery pressure that
was associated with mortality. This variable was assessed continu-
ously. I would say, however, that patients who have pulmonary
artery pressures after the hemi-Fontan in the 16– to 18–mm Hg
range are relatively poor candidates but not contraindicated for
completion operations, especially if a fenestration is done. As noted
in Discussion Figure 1, pre-Fontan pulmonary artery pressures of
greater than 12 to 14 begin to be associated with increased risk.
Fenestration has been shown to take high-risk patients and make
them into low-risk patients, which I think our data tend to support.
We could not identify any difference in mortality, hospital stay,
or hemodynamics in patients with extracardiac versus lateral-
tunnel Fontan operations. There were no deaths at all in patients
with single-punch fenestration lateral-tunnel operations. In the
patients with extracardiac Fontan operations, the only thing that
was slightly different was that their oxygen saturation levels were
slightly higher postoperatively, and their duration of effusion was
slightly higher than that in the lateral-tunnel group, probably
reflecting the fact that the fenestration was not as reliably per-
formed with a side-by-side fenestration in an extracardiac conduit.
We now generally remove the chest tubes on the first postoper-
ative day if there is no drainage, and we have not found a signifi-
cant increase in chylous effusions later with that policy. This also
limits, clearly, the hospital stay in these patients.
Discussion Figure 1. Relationship between pulsatile pressure
at the pre-Fontan catheterization and probability of operative
mortality.
